CompletedPhase 3

Budesonide Treatment for Lymphocytic Colitis

Germany40 participantsStarted 2002-01

Plain-language summary

The purpose of this study is to determine whether orale budesonide is effective in the treatment of lymphocytic colitis

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * lymphocytic colitis * diarrhea * effective contraception * written informed consent Exclusion Criteria: * other forms if IBD * celiac disease * infectious colitis * history of colonic surgery * use of budesonide, 5-ASA, steroids within th previous 4 weeks * pregnancy, lactation

What they're measuring

Proportion of patients in clinical remission after 6 weeks

Trial details

NCT IDNCT00180050

SponsorTechnische Universität Dresden

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2006-08

View on ClinicalTrials.gov More Microscopic Colitis trials